Two new small molecule donors (BDT-RO and BDT-RN) with esterified rhodanine (RE) as the terminal group are designed and synthesized. By combining with the fused-ring acceptor IDIC, a high PCE of over 9.0% is achieved by BDT-RO, and its isomer BDT-RN also shows a PCE close to 8.4%.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: